City of Hope Medical Center Clinical Trials
Sponsors / City of Hope Medical Center
The ClinicalTrials.gov registry records 594 trials led by City of Hope Medical Center. Across the portfolio, 152 are in recruitment, 151 are active non-recruiting, and 230 have reached completion. 31 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Across the portfolio, planned enrollment totals 1,082,560 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
594
Total Trials
152
Recruiting
151
Other Active
230
Completed
31
Terminated / Withdrawn
1,082,560
Total Enrollment
Termination reasons: Other48% · Recruitment35% · Efficacy6% · PI/or_Site3% · Funding3% · Safety3%
Recent Terminations
- Breast Cancer"Lack of enrollment to meet the primary and secondary study goals"
- Cervical Carcinoma"Feasibility issues"
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities"Due to the budget issues, the study discontinued at Phase II."
- Recurrent Colorectal Carcinoma"Poor Accrual"
- NCT01752231 Stopped Aug 2017Normal Volunteers"Feasibility issues."
- Recurrent Diffuse Large B-Cell Lymphoma"Withdrawal of sponsor support"
- Estrogen Receptor-positive Breast Cancer"Study closed after it became too difficult to interest patients in participating."
- Liver Metastases"Slow accrual."
- Hepatocellular Cancer"Due to Sorafenib became first line treatment for HCC, the designed treatment became less competitive. The company Sanofi decided not to continue to support"
- Cancer Survivor"Proposal will not be submitted and low accrual."
Active Trials (151 total)
- NCT04200443
- NCT06195891
- NCT07395050
- NCT03178617
- NCT03479268
- NCT04887805
- NCT05014646
- NCT06580015
- NCT06735690
- NCT07037004
- NCT05707273
- NCT04590872
- NCT07365306
- NCT03303846
- NCT07275216
- NCT03057795
- NCT03523975
- NCT04158635
- NCT05081492
- NCT07218913